Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue

Brain, Behavior, and Immunity

Volumn 25, Issue 7, 2011, Pages 1498-1502

  Korenromp, Ingrid H E ^a,b   Grutters, Jan C ^a,b   van den Bosch, Jules M M ^a,b   Zanen, Pieter ^a,b   Kavelaars, Annemieke ^b   Heijnen, Cobi J ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Chronic fatigue; Clinical remission; Cytokines; Sarcoidosis; Th1 Th2 balance

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CHECKLIST INDIVIDUAL STRENGTH; CHRONIC FATIGUE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FATIGUE; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS OF VARIANCE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; REMISSION; SARCOIDOSIS; SUPERNATANT; TH1 TH2 BALANCE; TH2 CELL;

ADULT; CHEMOKINES; CHRONIC DISEASE; CYTOKINES; DATABASES, FACTUAL; FATIGUE; FEMALE; HUMANS; MALE; QUESTIONNAIRES; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; TH2 CELLS;

EID: 80052747283     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.06.004     Document Type: Article

References (43)

1. Baughman R.P., Lower E.E., du Bois R.M. Sarcoidosis. Lancet 2003, 361:1111-1118.
2. Bennett B.K., Hickie I.B., Vollmer-Conna U.S., Quigley B., Brennan C.M., Wakefield D., et al. The relationship between fatigue, psychological and immunological variables in acute infectious illness. Aust. N. Z. J. Psychiatry 1998, 32:180-186.
3. Bluthe R.M., Castanon N., Pousset F., Bristow A., Ball C., Lestage J., et al. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 1999, 24:301-311.
4. Bluthe R.M., Lestage J., Rees G., Bristow A., Dantzer R. Dual effect of central injection of recombinant rat interleukin-4 on lipopolysaccharide-induced sickness behavior in rats. Neuropsychopharmacology 2002, 26:86-93.
5. Broderick G., Fuite J., Kreitz A., Vernon S.D., Klimas N., Fletcher M.A. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav. Immun. 2010, 24:1209-1217.
6. Capuron L., Raison C.L., Musselman D.L., Lawson D.H., Nemeroff C.B., Miller A.H. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am. J. Psychiatry 2003, 160:1342-1345.
7. Capuron L., Ravaud A., Gualde N., Bosmans E., Dantzer R., Maes M., et al. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 2001, 26:797-808.
8. Constant A., Castera L., Dantzer R., Couzigou P., de Ledinghen L., Motes-Mainard J., et al. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms. J. Clin. Psychiatry 2005, 66:1050-1057.
9. Costabel U., Hunninghake G.W. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American thoracic society. European respiratory society. World association for sarcoidosis and other granulomatous disorders. Eur. Respir. J. 1999, 14:735-737.
10. Costabel U., Ohshimo S., Guzman J. Diagnosis of sarcoidosis. Curr. Opin. Pulm. Med. 2008, 14:455-461.
11. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav. Immun. 2001, 15:7-24.
12. Dantzer R. Cytokine, sickness behavior, and depression. Neurol. Clin. 2006, 24:441-460.
13. Dantzer R. Cytokine, sickness behavior, and depression. Immunol. Allergy Clin. North Am. 2009, 29:247-264.
14. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
15. De Jager W., te Velthuis H., Prakken B.J., Kuis W., Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab Immunol. 2003, 10:133-139.
16. De Kleijn W.P., De Vries J., Lower E.E., Elfferich M.D., Baughman R.P., Drent M. Fatigue in sarcoidosis: a systematic review. Curr. Opin. Pulm. Med. 2009, 15:499-506.
17. De Vries J., Rothkrantz-Kos S., van Dieijen-Visser M.P., Drent M. The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2004, 21:127-136.
18. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 10(MCP-1): an overview. J. Interferon Cytokine Res. 2009, 29:313-326.
19. Dutch Lung foundation. Lung Diseases, facts and numbers, Ch. Interstitial Lung Diseases. 2008: 71-78.
20. Eskandari F., Webster J.I., Sternberg E.M. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res. Ther. 2003, 5:251-265.
21. Fletcher M.A., Zeng X.R., Barnes Z., Levis S., Klimas N.G. Plasma cytokines in women with chronic fatigue syndrome. J. Transl. Med. 2009, 7.
22. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann. Intern. Med. 1994, 121:953-959.
23. Gaab J., Rohleder N., Heitz V., Engert V., Schad T., Schurmeyer T.H., et al. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology 2005, 30:188-198.
24. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12:123-137.
25. Hsu F.C., Kritchevsky S.B., Liu Y., Kanaya A., Newman A.B., Perry S.E., et al. Association between inflammatory components and physical function in the health, aging, and body composition study: a principal component analysis approach. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64:581-589.
26. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N. Engl. J. Med. 2007, 357:2153-2165.
27. Korenromp, I.H., Heijnen, C.J., Vogels, O.J., van den Bosch, J.M., Grutters, J.C., in preparation. Characterization of chronic fatigue in sarcoidosis in clinical remission. Chest.
28. Lorusso L., Mikhaylova S.V., Capelli E., Ferrari D., Ngonga G.K., Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun. Rev. 2009, 8:287-291.
29. Lotrich F.E., Rabinovitz M., Gironda P., Pollock B.G. Depression following pegylated interferon-alpha: characteristics and vulnerability. J. Psychosom. Res. 2007, 63:131-135.
30. Lyall M., Peakman M., Wessely S. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J. Psychosom. Res. 2003, 55:79-90.
31. Mollers M., Aries S.P., Dromann D., Mascher B., Braun J., Dalhoff K. Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax 2001, 56:487-493.
32. Mommersteeg P.M., Vermetten E., Kavelaars A., Geuze E., Heijnen C.J. Hostility is related to clusters of T-cell cytokines and chemokines in healthy men. Psychoneuroendocrinology 2008, 33:1041-1050.
33. Natelson B.H., Haghighi M.H., Ponzio N.M. Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clin. Diagn. Lab Immunol. 2002, 9:747-752.
34. Prather A.A., Rabinovitz M., Pollock B.G., Lotrich F.E. Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality. Brain Behav. Immun. 2009, 23:1109-1116.
35. Raetz C.R., Whitfield C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 2002, 71:635-700.
36. Silverman M.N., Heim C.M., Nater U.M., Marques A.H., Sternberg E.M. Neuroendocrine and immune contributors to fatigue. PM. R. 2010, 2:338-346.
37. Ten Klooster P.M., Veehof M.M., Taal E., van Riel P.L., van de Laar M.A. Changes in priorities for improvement in patients with rheumatoid arthritis during 1year of anti-tumour necrosis factor treatment. Ann. Rheum. Dis. 2007, 66:1485-1490.
38. Ter Wolbeek M., van Doornen L.J., Kavelaars A., van de Putte E.M., Schedlowski M., Heijnen C.J. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents. Brain Behav. Immun. 2007, 21:1063-1074.
39. Vercoulen J.H., Swanink C.M., Fennis J.F., Galama J.M., van der Meer J.W., Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J. Psychosom. Res. 1994, 38:383-392.
40. Vogelaar L., van 't Spijker A., van der Woude C.J. The impact of biologics on health-related quality of life in patients with inflammatory bowel disease. Clin. Experiment. Gastroenterol. 2009, 2:102-109.
41. Wolfe F., Michaud K. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24, 831 patients. J. Rheumatol. 2004, 31:2115-2120.
42. Zissel G., Prasse A., Muller-Quernheim J. Sarcoidosis-immunopathogenetic concepts. Semin. Respir. Crit. Care Med. 2007, 28:3-14.
43. Zissel G. Immunologic response of sarcoidosis. Semin. Respir. Crit. Care Med. 2010, 31:390-403.